Anixa Biosciences Inc — Director's Dealing 2012

Dec 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-11-30

Reporting Person: Williams Kent B. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-30	Employee Stock Option	$0.201	A	60000	Acquired	2017-11-30	Common Stock (60000)	Direct
2012-11-30	Employee Stock Option	$0.211	A	1000000	Acquired	2022-11-30	Common Stock (1000000)	Direct

Footnotes

F1: Right-To-Buy, pursuant to the CopyTele, Inc. 2010 Share Incentive Plan.

F2: Right-To-Buy, on November 30, 2012, the reporting person was granted an option to purchase 1,000,000 shares of common stock. Options for 333,333 shares are immediately vested and the balance vests in two equal installments commencing on November 30, 2013.